US Patent 11833121 Composition and method for treating neurological disease
Patent 11833121 was granted and assigned to Adamas Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+50 properties)
Article (+423 characters)
US Patent 11833121 Composition and method for treating neurological disease
Article
Patent abstract
The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition comprising about 50 mg to about 400 mg of extended-release amantadine or a pharmaceutically acceptable salt thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Ana Cristina Pastini0
Glenn A. Meyer0
Joaquina Faour0
Marcelo Fernando Befumo0
Date of Patent
December 5, 2023
0Patent Application Number
171313230
Date Filed
December 22, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11833121 Composition and method for treating neurological disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
